Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis

Background. Fibroblast growth factor 21 (FGF-21) is a hormone that regulates glucose and lipid metabolism. High serum FGF-21 levels are associated with carotid atherosclerosis and coronary artery disease. This cross-sectional study aimed to assess the relationship between serum FGF-21 levels and car...

Full description

Saved in:
Bibliographic Details
Main Authors: Liang-Te Chiu, Chi-Di Hung, Lin Lin, Yu-Li Lin, Bang-Gee Hsu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2022/7098458
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408886130343936
author Liang-Te Chiu
Chi-Di Hung
Lin Lin
Yu-Li Lin
Bang-Gee Hsu
author_facet Liang-Te Chiu
Chi-Di Hung
Lin Lin
Yu-Li Lin
Bang-Gee Hsu
author_sort Liang-Te Chiu
collection DOAJ
description Background. Fibroblast growth factor 21 (FGF-21) is a hormone that regulates glucose and lipid metabolism. High serum FGF-21 levels are associated with carotid atherosclerosis and coronary artery disease. This cross-sectional study aimed to assess the relationship between serum FGF-21 levels and carotid-femoral pulse wave velocity (cfPWV) in patients on maintenance hemodialysis (HD). Methods. Blood samples and baseline characteristics were collected from 130 HD patients. Serum FGF-21 concentrations were measured with an enzyme-linked immunosorbent assay kit. Aortic stiffness was defined as a carotid-femoral pulse wave velocity (cfPWV) of more than 10 m/s. Results. Of the 130 HD patients, aortic stiffness was diagnosed in 54 (41.5%). Serum FGF-21 levels were significantly higher in those with aortic stiffness than those without P<0.001. The FGF-21 level was independently associated with aortic stiffness (odds ratio (OR): 1.008; 95% CI: 1.003–1.012; P=0.001) after adjusting for diabetes mellitus, age, hypertension, C-reactive protein, and body weight in multivariable logistic regression analysis. Multivariable forward stepwise linear regression analysis also confirmed that the logarithmically transformed FGF-21 level (β = 3.245, 95% CI: 1.593–4.987, P<0.001) was an independent predictor of cfPWV values. The area under the receiver operating characteristic (ROC) curve predicting aortic stiffness by the serum FGF-21 level was 0.693 (95% CI: 0.606–0.771, P<0.001). Conclusions. Serum FGF-21 level positively correlates with cfPWV and is also an independent predictor of aortic stiffness in maintenance HD patients.
format Article
id doaj-art-7ec38ca8034044efa882cc5e6f96a93a
institution Kabale University
issn 2090-0392
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-7ec38ca8034044efa882cc5e6f96a93a2025-08-20T03:35:40ZengWileyInternational Journal of Hypertension2090-03922022-01-01202210.1155/2022/7098458Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance HemodialysisLiang-Te Chiu0Chi-Di Hung1Lin Lin2Yu-Li Lin3Bang-Gee Hsu4Division of NephrologySchool of MedicineDivision of GastroenterologyDivision of NephrologyDivision of NephrologyBackground. Fibroblast growth factor 21 (FGF-21) is a hormone that regulates glucose and lipid metabolism. High serum FGF-21 levels are associated with carotid atherosclerosis and coronary artery disease. This cross-sectional study aimed to assess the relationship between serum FGF-21 levels and carotid-femoral pulse wave velocity (cfPWV) in patients on maintenance hemodialysis (HD). Methods. Blood samples and baseline characteristics were collected from 130 HD patients. Serum FGF-21 concentrations were measured with an enzyme-linked immunosorbent assay kit. Aortic stiffness was defined as a carotid-femoral pulse wave velocity (cfPWV) of more than 10 m/s. Results. Of the 130 HD patients, aortic stiffness was diagnosed in 54 (41.5%). Serum FGF-21 levels were significantly higher in those with aortic stiffness than those without P<0.001. The FGF-21 level was independently associated with aortic stiffness (odds ratio (OR): 1.008; 95% CI: 1.003–1.012; P=0.001) after adjusting for diabetes mellitus, age, hypertension, C-reactive protein, and body weight in multivariable logistic regression analysis. Multivariable forward stepwise linear regression analysis also confirmed that the logarithmically transformed FGF-21 level (β = 3.245, 95% CI: 1.593–4.987, P<0.001) was an independent predictor of cfPWV values. The area under the receiver operating characteristic (ROC) curve predicting aortic stiffness by the serum FGF-21 level was 0.693 (95% CI: 0.606–0.771, P<0.001). Conclusions. Serum FGF-21 level positively correlates with cfPWV and is also an independent predictor of aortic stiffness in maintenance HD patients.http://dx.doi.org/10.1155/2022/7098458
spellingShingle Liang-Te Chiu
Chi-Di Hung
Lin Lin
Yu-Li Lin
Bang-Gee Hsu
Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
International Journal of Hypertension
title Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
title_full Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
title_fullStr Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
title_full_unstemmed Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
title_short Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis
title_sort serum fibroblast growth factor 21 level is associated with aortic stiffness in patients on maintenance hemodialysis
url http://dx.doi.org/10.1155/2022/7098458
work_keys_str_mv AT liangtechiu serumfibroblastgrowthfactor21levelisassociatedwithaorticstiffnessinpatientsonmaintenancehemodialysis
AT chidihung serumfibroblastgrowthfactor21levelisassociatedwithaorticstiffnessinpatientsonmaintenancehemodialysis
AT linlin serumfibroblastgrowthfactor21levelisassociatedwithaorticstiffnessinpatientsonmaintenancehemodialysis
AT yulilin serumfibroblastgrowthfactor21levelisassociatedwithaorticstiffnessinpatientsonmaintenancehemodialysis
AT banggeehsu serumfibroblastgrowthfactor21levelisassociatedwithaorticstiffnessinpatientsonmaintenancehemodialysis